Literature DB >> 190649

Elevation of prostaglandin and cyclic AMP levels by arachidonic acid in primary epithelial cell cultures of C3H mouse mammary tumors.

S Burstein, G Gagnon, S A Hunter, D V Maudsley.   

Abstract

Arachidonic acid causes a sharp transient increase in cyclic AMP levels in primary epithelial cell cultures obtained from C3H mouse mammary tumors. The effect is evident within two minutes and is enhanced by theophylline or 3-isobutyl-1-methylxanthine. Maximum increase in cyclic AMP levels are observed with a dose of 100 mug/ml of arachidonic acid (AA). At higher dose levels the increase in cyclic AMP levels is reduced. Naproxen, an inhibitor of prostaglandin synthesis in this system markedly reduces the stimulation of cyclic AMP by arachidonic acid but it does not affect the increase in cyclic AMP levels observed after the addition of prostaglandin E's, epinephrine or cholera enterotoxin. Arachidonic acid, under the same conditions, also causes a significant elevation of PGE and PGF media levels which is slower and more sustained than the cAMP response. The data strongly suggest that a metabolic of arachidonic acid is responsible for the cyclic rise, however, it is not certain whether this is due to PGE2 or some other product.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 190649     DOI: 10.1016/0090-6980(77)90041-7

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  2 in total

1.  Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP.

Authors:  Bora Inceoglu; Karen Wagner; Nils H Schebb; Christophe Morisseau; Steven L Jinks; Arzu Ulu; Christine Hegedus; Tristan Rose; Robert Brosnan; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

2.  Flurbiprofen, a non-steroid anti-inflammatory agent, protects cells against hypoxic cell radiosensitizers in vitro.

Authors:  B C Millar; S Jinks; T J Powles
Journal:  Br J Cancer       Date:  1981-11       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.